Get the Weekly Intelligence Brief — top committee picks every Sunday.
CVSA · NYSE · STOCK

Covista (CVSA) Stock Analysis

Consumer Defensive Updated October 10, 2026
$129.69
52W $86.97 – $156.26
66/100
$4.40B
17.1
0.65
AI Committee Verdict
Buy
66/100
Conviction: High · 83% agreement · 6 analysts
+3.0%
-9.7%
0.31:1
High
⚠
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.

Is CVSA Bullish or Bearish?

Bullish. Innellis AI committee rates Covista Inc. (CVSA) Buy with a composite score of 66/100 , based on 6 analysts with 83% agreement. Last updated October 10, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +8.65 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -11.35 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+0.43 across 7 articles, 14d). Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • ROE of 17.8% shows genuine earnings power backing the valuation — Value
  • 4 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • News sentiment is positive (+0.43 across 7 articles, 14d) — News
Bear Case
  • Stochastic RSI (97.9) confirms overbought conditions.
  • Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
  • Risk/reward is unfavorable: 9.7% downside vs 3.0% upside.
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of October 10, 2026
Overall Committee Score
66/100
Agreement
83%
Analysts
6
Conviction
High
Sector Rank
Top 4%
of 72 Consumer Defensive peers
Value Analyst bullish
65 / 100 · High confidence
Classic value case: cheap on multiples with earnings power to back it up
+ ROE of 17.8% shows genuine earnings power backing the valuation
Growth Analyst bullish
68 / 100 · High confidence
Strong, accelerating growth with consistent execution
+ 4 consecutive earnings beats -- consistent execution
Technical Analyst neutral
58 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst bullish
70 / 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
71 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.43 across 7 articles, 14d)
Portfolio Manager bearish
30 / 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 64.7 to 66.3.

Analyst-level changes:
  • Technical Analyst: score 48->58 (+10).

Comparing 2026-10-09 to 2026-10-10 (1 day apart).

Technical Analysis

RSI (14)
67.6
Neutral
MACD Histogram
1.013
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Mixed
Support
$117.13
Resistance
$133.55
Bollinger %B
0.87
Inside Bands
Price vs Moving Averages
EMA 9
$126.72 Above
EMA 21
$126.07 Above
EMA 50
$126.43 Above
EMA 200
$121.67 Above

Fundamental Analysis

Valuation
89
Growth
81
Profitability
82
Financial Health
59
Cash Flow
70
Valuation
P/E Ratio 17.1×
P/B Ratio 3.04×
PEG Ratio 0.75
Dividend Yield 0.00%
52W High $156.26
52W Low $86.97
Quality & Growth
ROE 1739.5%
ROA 835.0%
Gross Margin 5733.8%
Operating Margin 1972.0%
Revenue Growth YoY —
Debt / Equity 0.63
AI Fundamental Assessment
P/E ratio of 17.1 (inexpensive relative to a 15-40x range); Price-to-book of 3.0x; PEG ratio of 0.7 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 17.4%; Return on assets of 8.4%; Net margin of 12.9%; Gross margin of 57.3%; Current ratio of 1.09 (tight short-term liquidity); Debt-to-equity of 0.63; Free cash flow per share is positive (11.54); Most recent quarter beat estimates by 8.3%; 4 consecutive earnings beats; EPS growth accelerating (-18.5% -> +5.6% QoQ); Analyst estimates falling over recent quarters
Get the Full CVSA Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime